Supplementary Table 2 from BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer <i>In Vivo</i>

crossref（2023）

Cited 0|Views5

No score

Abstract

Relationship between expression levels of the BCMab1 epitope and clinicopathological features of human bladder cancers.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined

Supplementary Table 2 from BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer &lt;i&gt;In Vivo&lt;/i&gt;